|
David P. Holveck was appointed President Chief Executive Officer and a Director of Endo in April 2008. Prior to joining Endo Mr. Holveck was President of Johnson & Johnson Development Corporation and Vice President Corporate Development of Johnson & Johnson since 2004. Mr. Holveck joined Johnson & Johnson as a company Group Chairman in 1999 following the acquisition of Centocor Inc. by Johnson & Johnson. Mr. Holveck was Chief Executive Officer of Centocor Inc. at the time of the acquisition. Mr. Holveck joined Centocor in 1983 and progressed through various executive positions. In 1992 he assumed the role of President and Chief Operating Officer and later that year was named President and Chief Executive Officer. Prior to joining Centocor he held positions at General Electric Company Corning Glass Works and Abbott Laboratories. Mr. Holveck is a member of the Board of Trustees for the Fund for West Chester University and the Board of Directors of the Eastern Technology Council. Effective April 7 2008� Mr. Holveck was appointed to the board of directors of Light Sciences Oncology Inc. and effective April 14 2008 he was appointed to the board of directors of Tengion Inc. | 